Navigation Links
American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
Date:2/7/2008

Accounts receivable, net 11,238 1,956

Inventories, net (3,071) (13,919)

Prepaid expenses (283) (576)

Accounts payable 1,875 5,961

Accrued expenses (131) 599

Accrued interest 2,439 19

Employee related liabilities (2,079) (1,758)

Deferred revenues and customer

deposits 1,027 (2,250)

Environmental remediation

reserves (293) (1,013)

Pension obligations, net 227 257

Other (560) (164)

Net Cash Provided (Used) by

Operating Activities 18,219 (3,981)

Cash Flows from Investing

Activities:

Capital expenditures (1,500) (1,430)

Discontinued operations -

collection of note receivable - 7,510

Net Cash Provided (Used) by

Investing Activities (1,500) 6,080

Cash Flows from Financing

Activities:

Payments of long-term debt (62) (7,287)

Issuances of common stock 49 -

Excess tax benefit from stock

option exercises 28 -

Net Cash Used by Financing

Activities 15 (7,287)

Net Change in Cash and Cash

Equivalents 16,734
'/>"/>

SOURCE American Pacific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
2. American Red Cross Responds to Tornadoes in the Southeast
3. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
4. Massive American Red Cross Tornado Relief Effort Spans Five States
5. Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns
6. Vitals.com Goes Red for American Heart Month
7. American Heart Month: Cracking Open Heart Health Myths
8. Consumer Reports Poll: Americans Demand Health Reform But Are Unsure About How to Achieve it
9. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
10. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
11. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...nsumers tips and encourages them to, ,Speak Up,(T...July 25 /PRNewswire-USNewswire/ -- The Pennsylvani...l Patient Safety Day" which,is a national effort t...pate fully in their healthcare by asking questions...ery or illness., "We understand the important rol...
(Date:7/25/2008)...ing Exclusivity Begins -, CORONA, Calif., July 25... Inc. (NYSE: WPI ), a leading specialty pharmaceu... has commenced commercial,shipment of its Omeprazo...g,strength from its Davie, Florida manufacturing f...s 180 days of marketing exclusivity for being the,...
(Date:7/25/2008)...iance to be presented at Fenway Park ... 25 /PRNewswire/ -- CVS/pharmacy announced today,t... million in just 21 days,through its annual in-sto...the seventh year of the annual fundraising effort ...or ALS research. This year,s fundraiser took,place...
(Date:7/25/2008)... Group of New York will present an educational mee...pecially designed for seniors. The lecture will be...ritts Road, Farmingdale, NY 11735, 1:00 to 2:00 p....freshments will be provided. The phone number for ... Hicksville and Hauppauge, NY (PRWEB) ...
Breaking Medicine News(10 mins):Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3
...t University School of Medicine were expecting a s...nstead, a semi-conscious,// vomiting “patient” was...e were asked to help manage the case. “SimMan?,” ...t, is more than a typical mannequin. The simulated...
...or money or drugs, reveals a large representative ...ually Transmitted// Infections. The authors anal...scents taking part in a study tracking the long te...untry (National Longitudinal Study of Adolescent H...
...died and nearly 2000 suffered 'moderate to severe ...nd given in the hospitals.// These are just a few ...corded in all 173 NHS trusts in England during the...s information was published by the Healthcare Comm...
...in a new project they've begun to draw out a new k... people// are susceptible or resistant to certain ...of the project that is being undertaken by the res...eleased yesterday, the 10th August, and it is to b...
Other Medicine News:Health News:Computerized Patient Used to Teach Science to Medical Students 2Health News:More than 3% of US Teens Have Exchanged Sex for Money or Drugs 2Health News:Researchers from Emory University Undertake A New Genetic Mapping 2
(Date:7/22/2008)...firms Tyrima Exhibits Excellent Drug-Like ...Support Initiation of Phase II Clinical Trials -, .../ -- CeNeRx BioPharma,Inc., a clinical stage comp...tments for diseases of the central nervous system,...te Tyrima(TM) into Phase II trials for the,treatme...
(Date:7/22/2008)... the Importance to Patients of Passing a ...HMOND, Va., July 22 /- Insm... biologics and biopharmaceuticals, today,announced...resent at a,Congressional briefing on Friday, July...tablishing an approval pathway for follow-on,biolo...
(Date:7/22/2008)...motherapy and pegylated enzyme produces signifi...alone - - Pegylated enzyme well t...all/ -- Halozyme Therapeutics,Inc. (Nasdaq: HALO...mercializing products targeting the extracellular ...ve pre-clinical animal efficacy data,for its pegyl...
(Date:7/22/2008)...ser Lipolysis Technology in the European ...ly 22 /- Cynosure, Inc.,(Na...r of a broad array of,light-based aesthetic treatm... Smartlipo MPX(TM), the company,s high-powered, du... and tighten skin through collagen,remodeling. The...
Breaking Medicine Technology:CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3ExonHit and bioMerieux Amend Their Strategic Partnership 2522 1ExonHit and bioMerieux Amend Their Strategic Partnership 2522 2ExonHit and bioMerieux Amend Their Strategic Partnership 2522 3Looking Older 3F How Square is Your Jaw Line 3F 1177 1Looking Older 3F How Square is Your Jaw Line 3F 1177 2Uses of medications in psychoanalysis 9315 1Uses of medications in psychoanalysis 9315 25 Factors Help Predict Psychosis in Children 9314 15 Factors Help Predict Psychosis in Children 9314 25 Factors Help Predict Psychosis in Children 9314 3
...LONA, SPAIN and SEATTLE, WA -- (MARKET WIRE) -- Ju...AQ: TGEN) today is,reporting data from the dose es...udy of tgAAC94 in patients with inflammatory,arthr... the,University of Washington School of Medicine, ...dish Medical Center, practicing,physician with Sea...
...APOLIS, June 13, 2007 /PRNewswire/ -- Two studies ...affect body sway at peak,plasma levels, nor did it...emory performance in patients who suffer from chro...ented at the 21st,Annual Meeting of the Associated...a are important because they show that ROZEREM may...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 2Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 4Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 5
... a potent naturally occurring androgen produced fr... 5a-reductase [1]. The concentrations of 5a-reduc...cluding genital skin and hair follicles, and are l...with the nuclear membrane. DHT exerts its biologi...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc.
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures.
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential.
Medicine Products: